Dr. Martens plc (LON:DOCS – Get Free Report) insider Giles Wilson bought 32,640 shares of the company’s stock in a transaction that occurred on Tuesday, March 25th. The shares were purchased at an average price of GBX 54 ($0.70) per share, with a total value of £17,625.60 ($22,813.36).
Giles Wilson also recently made the following trade(s):
- On Tuesday, March 11th, Giles Wilson purchased 269 shares of Dr. Martens stock. The stock was purchased at an average price of GBX 56 ($0.72) per share, for a total transaction of £150.64 ($194.98).
- On Tuesday, February 11th, Giles Wilson acquired 207 shares of Dr. Martens stock. The shares were purchased at an average cost of GBX 73 ($0.94) per share, with a total value of £151.11 ($195.59).
- On Monday, January 13th, Giles Wilson bought 222 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 68 ($0.88) per share, for a total transaction of £150.96 ($195.39).
Dr. Martens Trading Down 1.7 %
DOCS stock opened at GBX 52 ($0.67) on Friday. The business has a fifty day moving average price of GBX 64.61 and a 200 day moving average price of GBX 63.45. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13. Dr. Martens plc has a fifty-two week low of GBX 49.32 ($0.64) and a fifty-two week high of GBX 99.40 ($1.29). The stock has a market capitalization of £504.80 million, a price-to-earnings ratio of 7.37, a P/E/G ratio of 6.40 and a beta of 0.11.
Dr. Martens Cuts Dividend
Dr. Martens Company Profile
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Read More
- Five stocks we like better than Dr. Martens
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Election Stocks: How Elections Affect the Stock Market
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.